TickerFacts.

Cresco Labs Inc. (CRLBF): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

$20.73M
Year ended 2025-12-31
$166.39M2023-12-31: -$25.31M2024-12-31: $166.39M2025-12-31: $20.73M$20.73M
2023-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31$20.73M-87.5%2026-03-06, From 2025-01-01
2024-12-31$166.39Mn/m2026-03-06, From 2024-01-01
2023-12-31-$25.31Mn/a2025-03-14, From 2023-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Cresco Labs Inc. (CRLBF)2025-12-31$20.73M-87.5%
Ascend Wellness Holdings, Inc. (AAWH)2025-12-31$56.52M-20.3%
USANA Health Sciences Inc (USNA)2026-01-03$69.99M-13.4%
Trulieve Cannabis Corp. (TRLV)2025-12-31$261.13M+24.0%
Curaleaf Holdings, Inc. (CURLF)2025-12-31$222.06M-13.3%
Jushi Holdings Inc. (JUSH)2025-12-31$35.84M-12.1%
biote Corp. (BTMD)2025-12-31$39.22M+11.5%
Glass House Brands Inc. (GLAS)2025-12-31-$1.53Mn/m
Marimed Inc. (MRMD)2025-12-31$5.29M-49.7%

Compare CRLBF, AAWH, USNA, TRLV side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗